Balacovin: Kerala firm PNB Vesper Life gets nod for phase 3 clinical trial of Covid drug
There are 28 post-covid long-term complications that the WHO has identified. (Representational Image) A Covid-19 drug manufactured by Kerala-based company, PNB Vesper, has received nod by DCGI to conduct Phase 3 clinical trials. The company will be conducting a nationwide multi-centred clinical trial of the drug- PNB-001 (GPP-BALACOVIN), on Covid-19 patients who are hospitalised and … Read more